solution by Industry
Integrated Bioprocessing Systems & Turnkey Biopharmaceutical Factory Solutions
From bioreactors and aseptic filling lines to cleanroom and water systems — complete GMP-compliant manufacturing infrastructure for biologics producers worldwide.
The Industry at a Glance
The global biopharmaceutical manufacturing market reached $449.9 billion in 2024 and is projected to hit $967.7 billion by 2033, growing at a CAGR of 8.9%. Asia-Pacific is poised to grow at the fastest CAGR of 21.6%, driven by increasing healthcare access and technological advancements. With expanding biosimilar pipelines, rising demand for monoclonal antibodies, and government-backed capacity build-outs across emerging markets, manufacturers need scalable, GMP-ready bioprocessing infrastructure — from upstream cell culture through aseptic fill-finish.

Where Our Products Are Used
-
1
IV Infusion Production Lines
Complete systems for Non-PVC soft bag, PP bottle, and glass bottle IV solutions, from compounding to filling and sterilization. -
2
Ampoule & Vial Filling Lines
High-speed aseptic filling and sealing lines for injectable formulations, fully compliant with cGMP requirements. -
3
Oral Solid Dosage (OSD) Plants
Integrated granulation, tablet pressing, capsule filling, coating, and blister packaging for tablets and capsules. -
4
Pharmaceutical Water Treatment Systems
Purified water (PW) and water for injection (WFI) generation, storage, and distribution systems meeting pharmacopeia standards. -
5
Cleanroom & HVAC Engineering
Full facility design including classified cleanrooms, HVAC zoning, and environmental monitoring systems.
Pain Points & Solutions
Why Choose Us
-
2,500+ production lines and 40+ turnkey projects delivered across 60+ countries
-
Near 20 years of pharmaceutical and bioprocessing engineering expertise
-
4 self-owned factories — pharma machinery, water treatment, cleanroom systems, and automated packaging under vertical quality control
-
End-to-end project scope — consulting, process design, equipment manufacturing, installation, validation, technology transfer, and operator training
-
Multi-standard GMP compliance (EU, FDA, WHO, PIC/S) embedded in every deliverable
-
Customized bioprocessing configurations matched to each client’s product portfolio, regulatory environment, and facility constraints
Success Snapshot
-
National Vaccine Manufacturer
Delivered a complete biologics production facility including bioreactor systems, aseptic vial filling line, WFI system, and cleanroom. The facility achieved WHO GMP prequalification within 6 months of commissioning, enabling domestic vaccine supply for national immunization programs.
-
Emerging Biotech Company
Designed and installed a turnkey monoclonal antibody production workshop — from upstream bioprocessing through fill-finish and packaging. Production capacity reached 2 million vials/year, and the client secured regional regulatory approval on the first submission.
Trusted by Industry Leaders
-
“IVEN handled the full scope — bioreactors, water for injection, cleanroom, and filling lines — all validated to WHO GMP. We couldn’t have built this facility without a single integrated partner.”
Dr. H
Technical Director
-
“Their engineering team understood our biologics process requirements from day one. The facility was delivered on schedule and passed our regulatory inspection without a single major finding.”
Mr. S
VP of Manufacturing









